Dilshaad Basrai Vad

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Dilshaad Basrai Vad sits in the upper half of US sponsors by registered trial count (#7,390 of 15,751 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Dilshaad Basrai Vad: 1 sponsored US clinical trial, 1 recruiting.

Dilshaad Basrai Vad sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Fall Risk, with 1 trials.

Mid-pack sponsor footprint

Dilshaad Basrai Vad is in the upper half of sponsors by trial count (#7,390 of 15,751 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

What is open in the Dilshaad Basrai Vad pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Fall Risk (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.